Hilton CFO Jacobs exercises options, sells 151,050 shares
The sale prices are weighted averages across multiple trades, with a separate execution-price range stated for each sale tranche.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hilton Worldwide Holdings Inc. (HLT) Executive Vice President and Chief Financial Officer Kevin J. Jacobs exercised seven employee stock option tranches on October 29, 2026, acquiring 151,050 common shares. The options had exercise prices of $83.10, $93.33, $123.13, $150.67, $146.19, $203.96 and $259.10 per share.
Jacobs sold 151,050 common shares in seven transactions that day at weighted-average prices of $353.175, $354.192, $355.059, $355.985, $357.235, $358.054 and $358.789 per share; each price covers multiple trades within a range stated in the transaction notes. No Rule 10b5-1 plan is reported. A family trust for which his spouse serves as trustee held 48,387 shares indirectly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F9 | 12,848 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F10 | 29,110 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F11 | 28,538 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F12 | 27,370 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F13 | 31,058 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F14 | 15,999 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F15 | 6,127 | $0.00 | $0.00 |
| Exercise | Common Stock | 12,848 | $83.10 | $1.07M |
| Exercise | Common Stock | 29,110 | $93.33 | $2.72M |
| Exercise | Common Stock | 28,538 | $123.13 | $3.51M |
| Exercise | Common Stock | 27,370 | $150.67 | $4.12M |
| Exercise | Common Stock | 31,058 | $146.19 | $4.54M |
| Exercise | Common Stock | 15,999 | $203.96 | $3.26M |
| Exercise | Common Stock | 6,127 | $259.10 | $1.59M |
| Sale | Common Stock F1 | 7,864 | $353.175 | $2.78M |
| Sale | Common Stock F2 | 21,895 | $354.192 | $7.76M |
| Sale | Common Stock F3 | 38,108 | $355.059 | $13.53M |
| Sale | Common Stock F4 | 10,667 | $355.985 | $3.80M |
| Sale | Common Stock F5 | 28,531 | $357.235 | $10.19M |
| Sale | Common Stock F6 | 42,794 | $358.054 | $15.32M |
| Sale | Common Stock F7 | 1,191 | $358.789 | $427K |
| Holding | Common Stock F8 | -- | -- | -- |
Footnotes (15)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $352.555 to $353.555, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $353.58 to $354.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $354.595 to $355.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $355.60 to $356.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $356.65 to $357.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $357.66 to $358.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $358.675 to $359.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F8. Reflects indirect ownership by a family trust for which the reporting person's spouse serves as trustee.
- F9. The option vested in three equal annual installments beginning on March 3, 2020.
- F10. The option vested in three equal annual installments beginning on March 3, 2021.
- F11. The option vested in three equal annual installments beginning on March 3, 2022.
- F12. The option vested in three equal annual installments beginning on March 3, 2023.
- F13. The option vested in three equal annual installments beginning on March 3, 2024.
- F14. The option vests in three equal annual installments beginning on March 3, 2025.
- F15. The option vests in three equal annual installments beginning on March 3, 2026.
Key Figures
Key Terms
Employee Stock Option (right to buy) financial
weighted average price financial
indirect ownership financial
three equal annual installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When did Kevin J. Jacobs's HLT options begin vesting?
AI-generated analysis. How Rhea-AI works. Not financial advice.